From: Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients
Serum parameters | Baseline IV alfacalcidol administration | 3 months after switch to oral alfacalcidol | 6 months after switch to oral alfacalcidol |
---|---|---|---|
Calcium, mmol/L (SD) | 2.34 (0.17) | 2.40 (0.18)** | 2.43 (0.17)** |
Phosphorus, mmol/L (SD) | 1.49 (0.44) | 1.58 (0.44) | 1.57 (0.50) |
Ca x PO4 (SD) | 3.49 (1.06) | 3.78 (1.07)* | 3.77 (1.18) |
Intact PTH, pmol/L (SD) | 79.7 (59) | 58.5 (56)** | 78.2 (77) |
Alkaline phosphatise (SD) | 142.3 (103) | 127.7 (96)* | 130.2 (103)* |
25(OH)D3, nmol/L (SD) | 55 (20) | 57 (24) | 50 (21)** |
1,25(OH) 2D3 (pmol/L) (SD) | 32 (19) | 38 (17)* | 40 (18)* |
Mean alfacalcidol dose (SD) | 2.1 μg 3 times a week (0.86) | 1.87 μg 3 times a week (0.92)* | 1.56 μg 3 times a week (0.79)** |